1 Brompheniramine Market Overview 1.1 Product Overview and Scope of Brompheniramine 1.2 Brompheniramine Segment by Type 1.2.1 Global Brompheniramine Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Oral Solution 1.2.3 Tablet 1.3 Brompheniramine Segment by Access Channel 1.3.1 Brompheniramine Sales Comparison by Access Channel: 2020 VS 2026 1.3.2 Hospital 1.3.3 Drug Store 1.4 Global Brompheniramine Market Size Estimates and Forecasts 1.4.1 Global Brompheniramine Revenue 2015-2026 1.4.2 Global Brompheniramine Sales 2015-2026 1.4.3 Brompheniramine Market Size by Region: 2020 Versus 2026 1.5 Brompheniramine Industry 1.6 Brompheniramine Market Trends 2 Global Brompheniramine Market Competition by Manufacturers 2.1 Global Brompheniramine Sales Market Share by Manufacturers (2015-2020) 2.2 Global Brompheniramine Revenue Share by Manufacturers (2015-2020) 2.3 Global Brompheniramine Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Brompheniramine Manufacturing Sites, Area Served, Product Type 2.5 Brompheniramine Market Competitive Situation and Trends 2.5.1 Brompheniramine Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Brompheniramine Players (Opinion Leaders) 3 Brompheniramine Retrospective Market Scenario by Region 3.1 Global Brompheniramine Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Brompheniramine Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Brompheniramine Market Facts & Figures by Country 3.3.1 North America Brompheniramine Sales by Country 3.3.2 North America Brompheniramine Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Brompheniramine Market Facts & Figures by Country 3.4.1 Europe Brompheniramine Sales by Country 3.4.2 Europe Brompheniramine Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Brompheniramine Market Facts & Figures by Region 3.5.1 Asia Pacific Brompheniramine Sales by Region 3.5.2 Asia Pacific Brompheniramine Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Brompheniramine Market Facts & Figures by Country 3.6.1 Latin America Brompheniramine Sales by Country 3.6.2 Latin America Brompheniramine Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Brompheniramine Market Facts & Figures by Country 3.7.1 Middle East and Africa Brompheniramine Sales by Country 3.7.2 Middle East and Africa Brompheniramine Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Brompheniramine Historic Market Analysis by Type 4.1 Global Brompheniramine Sales Market Share by Type (2015-2020) 4.2 Global Brompheniramine Revenue Market Share by Type (2015-2020) 4.3 Global Brompheniramine Price Market Share by Type (2015-2020) 4.4 Global Brompheniramine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Brompheniramine Historic Market Analysis by Access Channel 5.1 Global Brompheniramine Sales Market Share by Access Channel (2015-2020) 5.2 Global Brompheniramine Revenue Market Share by Access Channel (2015-2020) 5.3 Global Brompheniramine Price by Access Channel (2015-2020) 6 Company Profiles and Key Figures in Brompheniramine Business 6.1 Pfizer 6.1.1 Corporation Information 6.1.2 Pfizer Description, Business Overview and Total Revenue 6.1.3 Pfizer Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Pfizer Products Offered 6.1.5 Pfizer Recent Development 6.2 AMAG Pharmaceuticals 6.2.1 AMAG Pharmaceuticals Corporation Information 6.2.2 AMAG Pharmaceuticals Description, Business Overview and Total Revenue 6.2.3 AMAG Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.2.4 AMAG Pharmaceuticals Products Offered 6.2.5 AMAG Pharmaceuticals Recent Development 6.3 PAI 6.3.1 PAI Corporation Information 6.3.2 PAI Description, Business Overview and Total Revenue 6.3.3 PAI Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.3.4 PAI Products Offered 6.3.5 PAI Recent Development 6.4 USL Pharma 6.4.1 USL Pharma Corporation Information 6.4.2 USL Pharma Description, Business Overview and Total Revenue 6.4.3 USL Pharma Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.4.4 USL Pharma Products Offered 6.4.5 USL Pharma Recent Development 6.5 Watson Laboratories 6.5.1 Watson Laboratories Corporation Information 6.5.2 Watson Laboratories Description, Business Overview and Total Revenue 6.5.3 Watson Laboratories Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Watson Laboratories Products Offered 6.5.5 Watson Laboratories Recent Development 6.6 Teva 6.6.1 Teva Corporation Information 6.6.2 Teva Description, Business Overview and Total Revenue 6.6.3 Teva Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Teva Products Offered 6.6.5 Teva Recent Development 6.7 Ivax Pharmaceuticals 6.6.1 Ivax Pharmaceuticals Corporation Information 6.6.2 Ivax Pharmaceuticals Description, Business Overview and Total Revenue 6.6.3 Ivax Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Ivax Pharmaceuticals Products Offered 6.7.5 Ivax Pharmaceuticals Recent Development 6.8 Newtron Pharmaceuticals 6.8.1 Newtron Pharmaceuticals Corporation Information 6.8.2 Newtron Pharmaceuticals Description, Business Overview and Total Revenue 6.8.3 Newtron Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Newtron Pharmaceuticals Products Offered 6.8.5 Newtron Pharmaceuticals Recent Development 6.9 Nexgen Pharma 6.9.1 Nexgen Pharma Corporation Information 6.9.2 Nexgen Pharma Description, Business Overview and Total Revenue 6.9.3 Nexgen Pharma Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Nexgen Pharma Products Offered 6.9.5 Nexgen Pharma Recent Development 6.10 Endo International 6.10.1 Endo International Corporation Information 6.10.2 Endo International Description, Business Overview and Total Revenue 6.10.3 Endo International Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Endo International Products Offered 6.10.5 Endo International Recent Development 6.11 Novartis 6.11.1 Novartis Corporation Information 6.11.2 Novartis Brompheniramine Description, Business Overview and Total Revenue 6.11.3 Novartis Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Novartis Products Offered 6.11.5 Novartis Recent Development 6.12 Eon Pharma 6.12.1 Eon Pharma Corporation Information 6.12.2 Eon Pharma Brompheniramine Description, Business Overview and Total Revenue 6.12.3 Eon Pharma Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Eon Pharma Products Offered 6.12.5 Eon Pharma Recent Development 6.13 Merck 6.13.1 Merck Corporation Information 6.13.2 Merck Brompheniramine Description, Business Overview and Total Revenue 6.13.3 Merck Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.13.4 Merck Products Offered 6.13.5 Merck Recent Development 6.14 Tanta Pharmaceuticals 6.14.1 Tanta Pharmaceuticals Corporation Information 6.14.2 Tanta Pharmaceuticals Brompheniramine Description, Business Overview and Total Revenue 6.14.3 Tanta Pharmaceuticals Brompheniramine Sales, Revenue and Gross Margin (2015-2020) 6.14.4 Tanta Pharmaceuticals Products Offered 6.14.5 Tanta Pharmaceuticals Recent Development 7 Brompheniramine Manufacturing Cost Analysis 7.1 Brompheniramine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Brompheniramine 7.4 Brompheniramine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Brompheniramine Distributors List 8.3 Brompheniramine Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Brompheniramine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Brompheniramine by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Brompheniramine by Type (2021-2026) 10.2 Brompheniramine Market Estimates and Projections by Access Channel 10.2.1 Global Forecasted Sales of Brompheniramine by Access Channel (2021-2026) 10.2.2 Global Forecasted Revenue of Brompheniramine by Access Channel (2021-2026) 10.3 Brompheniramine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Brompheniramine by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Brompheniramine by Region (2021-2026) 10.4 North America Brompheniramine Estimates and Projections (2021-2026) 10.5 Europe Brompheniramine Estimates and Projections (2021-2026) 10.6 Asia Pacific Brompheniramine Estimates and Projections (2021-2026) 10.7 Latin America Brompheniramine Estimates and Projections (2021-2026) 10.8 Middle East and Africa Brompheniramine Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Brompheniramine Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Brompheniramine Sales (K Units) Comparison by Access Channel: 2020 VS 2026 Table 3. Global Brompheniramine Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Brompheniramine Manufacturers Covered in This Study Table 5. Global Brompheniramine Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Brompheniramine Sales Share by Manufacturers (2015-2020) Table 7. Global Brompheniramine Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Brompheniramine Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Brompheniramine Average Price (US$/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Brompheniramine Sales Sites and Area Served Table 11. Manufacturers Brompheniramine Product Types Table 12. Global Brompheniramine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Brompheniramine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brompheniramine as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Brompheniramine Players Table 16. Global Brompheniramine Sales (K Units) by Region (2015-2020) Table 17. Global Brompheniramine Sales Market Share by Region (2015-2020) Table 18. Global Brompheniramine Revenue (Million US$) by Region (2015-2020) Table 19. Global Brompheniramine Revenue Market Share by Region (2015-2020) Table 20. North America Brompheniramine Sales by Country (2015-2020) (K Units) Table 21. North America Brompheniramine Sales Market Share by Country (2015-2020) Table 22. North America Brompheniramine Revenue by Country (2015-2020) (US$ Million) Table 23. North America Brompheniramine Revenue Market Share by Country (2015-2020) Table 24. Europe Brompheniramine Sales by Country (2015-2020) (K Units) Table 25. Europe Brompheniramine Sales Market Share by Country (2015-2020) Table 26. Europe Brompheniramine Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Brompheniramine Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Brompheniramine Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Brompheniramine Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Brompheniramine Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Brompheniramine Revenue Market Share by Region (2015-2020) Table 32. Latin America Brompheniramine Sales by Country (2015-2020) (K Units) Table 33. Latin America Brompheniramine Sales Market Share by Country (2015-2020) Table 34. Latin America Brompheniramine Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Brompheniramine Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Brompheniramine Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Brompheniramine Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Brompheniramine Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Brompheniramine Revenue Market Share by Country (2015-2020) Table 40. Global Brompheniramine Sales (K Units) by Type (2015-2020) Table 41. Global Brompheniramine Sales Share by Type (2015-2020) Table 42. Global Brompheniramine Revenue (Million US$) by Type (2015-2020) Table 43. Global Brompheniramine Revenue Share by Type (2015-2020) Table 44. Global Brompheniramine Price (US$/Unit) by Type (2015-2020) Table 45. Global Brompheniramine Sales (K Units) by Access Channel (2015-2020) Table 46. Global Brompheniramine Sales Market Share by Access Channel (2015-2020) Table 47. Global Brompheniramine Sales Growth Rate by Access Channel (2015-2020) Table 48. Pfizer Brompheniramine Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 51. Pfizer Main Product Table 52. Pfizer Recent Development Table 53. AMAG Pharmaceuticals Brompheniramine Corporation Information Table 54. AMAG Pharmaceuticals Corporation Information Table 55. AMAG Pharmaceuticals Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 56. AMAG Pharmaceuticals Main Product Table 57. AMAG Pharmaceuticals Recent Development Table 58. PAI Brompheniramine Corporation Information Table 59. PAI Corporation Information Table 60. PAI Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 61. PAI Main Product Table 62. PAI Recent Development Table 63. USL Pharma Brompheniramine Corporation Information Table 64. USL Pharma Corporation Information Table 65. USL Pharma Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 66. USL Pharma Main Product Table 67. USL Pharma Recent Development Table 68. Watson Laboratories Brompheniramine Corporation Information Table 69. Watson Laboratories Corporation Information Table 70. Watson Laboratories Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 71. Watson Laboratories Main Product Table 72. Watson Laboratories Recent Development Table 73. Teva Brompheniramine Corporation Information Table 74. Teva Corporation Information Table 75. Teva Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 76. Teva Main Product Table 77. Teva Recent Development Table 78. Ivax Pharmaceuticals Brompheniramine Corporation Information Table 79. Ivax Pharmaceuticals Corporation Information Table 80. Ivax Pharmaceuticals Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 81. Ivax Pharmaceuticals Main Product Table 82. Ivax Pharmaceuticals Recent Development Table 83. Newtron Pharmaceuticals Brompheniramine Corporation Information Table 84. Newtron Pharmaceuticals Corporation Information Table 85. Newtron Pharmaceuticals Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 86. Newtron Pharmaceuticals Main Product Table 87. Newtron Pharmaceuticals Recent Development Table 88. Nexgen Pharma Brompheniramine Corporation Information Table 89. Nexgen Pharma Corporation Information Table 90. Nexgen Pharma Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 91. Nexgen Pharma Main Product Table 92. Nexgen Pharma Recent Development Table 93. Endo International Brompheniramine Corporation Information Table 94. Endo International Corporation Information Table 95. Endo International Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 96. Endo International Main Product Table 97. Endo International Recent Development Table 98. Novartis Brompheniramine Corporation Information Table 99. Novartis Corporation Information Table 100. Novartis Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 101. Novartis Main Product Table 102. Novartis Recent Development Table 103. Eon Pharma Brompheniramine Corporation Information Table 104. Eon Pharma Corporation Information Table 105. Eon Pharma Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 106. Eon Pharma Main Product Table 107. Eon Pharma Recent Development Table 108. Merck Brompheniramine Corporation Information Table 109. Merck Corporation Information Table 110. Merck Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 111. Merck Main Product Table 112. Merck Recent Development Table 113. Tanta Pharmaceuticals Brompheniramine Corporation Information Table 114. Tanta Pharmaceuticals Corporation Information Table 115. Tanta Pharmaceuticals Brompheniramine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020) Table 116. Tanta Pharmaceuticals Main Product Table 117. Tanta Pharmaceuticals Recent Development Table 118. Sales Base and Market Concentration Rate of Raw Material Table 119. Key Suppliers of Raw Materials Table 120. Brompheniramine Distributors List Table 121. Brompheniramine Customers List Table 122. Market Key Trends Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 124. Key Challenges Table 125. Global Brompheniramine Sales (K Units) Forecast by Type (2021-2026) Table 126. Global Brompheniramine Sales Market Share Forecast by Type (2021-2026) Table 127. Global Brompheniramine Revenue (Million US$) Forecast by Type (2021-2026) Table 128. Global Brompheniramine Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 129. Global Brompheniramine Sales (K Units) Forecast by Access Channel (2021-2026) Table 130. Global Brompheniramine Revenue (Million US$) Forecast by Access Channel (2021-2026) Table 131. Global Brompheniramine Sales (K Units) Forecast by Region (2021-2026) Table 132. Global Brompheniramine Sales Market Share Forecast by Region (2021-2026) Table 133. Global Brompheniramine Revenue Forecast by Region (2021-2026) (US$ Million) Table 134. Global Brompheniramine Revenue Market Share Forecast by Region (2021-2026) Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Brompheniramine Figure 2. Global Brompheniramine Sales Market Share by Type: 2020 VS 2026 Figure 3. Oral Solution Product Picture Figure 4. Tablet Product Picture Figure 5. Global Brompheniramine Consumption Market Share by Access Channel: 2020 VS 2026 Figure 6. Hospital Figure 7. Drug Store Figure 8. Global Brompheniramine Market Size 2015-2026 (US$ Million) Figure 9. Global Brompheniramine Sales Capacity (K Units) (2015-2026) Figure 10. Global Brompheniramine Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Brompheniramine Sales Share by Manufacturers in 2020 Figure 12. Global Brompheniramine Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Brompheniramine Revenue in 2019 Figure 14. Brompheniramine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Brompheniramine Sales Market Share by Region (2015-2020) Figure 16. Global Brompheniramine Sales Market Share by Region in 2019 Figure 17. Global Brompheniramine Revenue Market Share by Region (2015-2020) Figure 18. Global Brompheniramine Revenue Market Share by Region in 2019 Figure 19. North America Brompheniramine Sales Market Share by Country in 2019 Figure 20. North America Brompheniramine Revenue Market Share by Country in 2019 Figure 21. U.S. Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 22. U.S. Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 24. Canada Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Brompheniramine Sales Market Share by Country in 2019 Figure 26. Europe Brompheniramine Revenue Market Share by Country in 2019 Figure 27. Germany Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 28. Germany Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 30. France Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. U.K. Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 32. U.K. Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 34. Italy Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 36. Russia Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Brompheniramine Sales Market Share by Region in 2019 Figure 38. Asia Pacific Brompheniramine Revenue Market Share by Region in 2019 Figure 39. China Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 40. China Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 42. Japan Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 44. South Korea Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 46. India Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 48. Australia Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 50. Taiwan Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 52. Indonesia Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 54. Thailand Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 56. Malaysia Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 58. Philippines Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 60. Vietnam Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Brompheniramine Sales Market Share by Country in 2019 Figure 62. Latin America Brompheniramine Revenue Market Share by Country in 2019 Figure 63. Mexico Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 64. Mexico Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 66. Brazil Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 68. Argentina Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Brompheniramine Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Brompheniramine Revenue Market Share by Country in 2019 Figure 71. Turkey Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 72. Turkey Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 74. Saudi Arabia Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. U.A.E Brompheniramine Sales Growth Rate (2015-2020) (K Units) Figure 76. U.A.E Brompheniramine Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Brompheniramine by Type (2015-2020) Figure 78. Sales Market Share of Brompheniramine by Type in 2019 Figure 79. Revenue Share of Brompheniramine by Type (2015-2020) Figure 80. Revenue Market Share of Brompheniramine by Type in 2019 Figure 81. Global Brompheniramine Sales Growth by Type (2015-2020) (K Units) Figure 82. Global Brompheniramine Sales Market Share by Access Channel (2015-2020) Figure 83. Global Brompheniramine Sales Market Share by Access Channel in 2019 Figure 84. Global Revenue Share of Brompheniramine by Access Channel (2015-2020) Figure 85. Global Revenue Share of Brompheniramine by Access Channel in 2020 Figure 86. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. PAI Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. USL Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Watson Laboratories Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Ivax Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Newtron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Nexgen Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Endo International Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Eon Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Tanta Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Price Trend of Key Raw Materials Figure 101. Manufacturing Cost Structure of Brompheniramine Figure 102. Manufacturing Process Analysis of Brompheniramine Figure 103. Brompheniramine Industrial Chain Analysis Figure 104. Channels of Distribution Figure 105. Distributors Profiles Figure 106. Porter's Five Forces Analysis Figure 107. North America Brompheniramine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 108. North America Brompheniramine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Europe Brompheniramine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 110. Europe Brompheniramine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Latin America Brompheniramine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 112. Latin America Brompheniramine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Middle East and Africa Brompheniramine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 114. Middle East and Africa Brompheniramine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Asia Pacific Brompheniramine Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 116. Asia Pacific Brompheniramine Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 117. Bottom-up and Top-down Approaches for This Report Figure 118. Data Triangulation Figure 119. Key Executives Interviewed

Pfizer AMAG Pharmaceuticals PAI USL Pharma Watson Laboratories Teva Ivax Pharmaceuticals Newtron Pharmaceuticals Nexgen Pharma Endo International Novartis Eon Pharma Merck Tanta Pharmaceuticals